The historical rank and industry rank for Gyre Therapeutics's Days Inventory or its related term are showing as below:
GYRE'
s Days Inventory Range Over the Past 10 Years
Min: 409.52 Med: 450.9 Max: 519.22
Current: 409.52
During the past 3 years, Gyre Therapeutics's highest Days Inventory was 519.22. The lowest was 409.52. And the median was 450.90.
GYRE's Days Inventory is ranked worse than 77.85% of 650
companies
in the Biotechnology industry
Industry Median: 190.305
vs GYRE: 409.52
Gyre Therapeutics's Days Inventory
declined
from Dec. 2021 (519.22) to Dec. 2023 (409.52).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Gyre Therapeutics's Inventory Turnover for the
six
months ended in Dec. 2023 was 0.89.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gyre Therapeutics's Inventory-to-Revenue for the
six
months ended in Dec. 2023 was 0.05.
Gyre Therapeutics Days Inventory Historical Data
The historical data trend for Gyre Therapeutics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Gyre Therapeutics Days Inventory Chart
Gyre Therapeutics Annual Data
Trend
Dec21
Dec22
Dec23
Days Inventory
519.22
450.90
409.52
Gyre Therapeutics Semi-Annual Data
Dec21
Dec22
Dec23
Days Inventory
519.22
450.90
409.52
Competitive Comparison of Gyre Therapeutics's Days Inventory
For the Biotechnology subindustry, Gyre Therapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gyre Therapeutics's Days Inventory Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gyre Therapeutics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Gyre Therapeutics's Days Inventory falls into.
Gyre Therapeutics Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Gyre Therapeutics's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gyre Therapeutics (NAS:GYRE) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Gyre Therapeutics's Inventory Turnover for the
six
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Gyre Therapeutics's Inventory to Revenue for the
six
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Gyre Therapeutics Days Inventory Related Terms
Thank you for viewing the detailed overview of Gyre Therapeutics's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Gyre Therapeutics (Gyre Therapeutics) Business Description
Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GYRE has been successfully added to your